Saturday, February 14, 2026

HLB’s Liragratinib: A Game-Changer in Cholangiocarcinoma Treatment Revealed at ASCO GI 2026!

HLB's lirafugratinib shows promise as a precision oncology drug, targeting FGFR2 in cancer treatment. FDA application expected soon.

LG Electronics Named Most Awarded Company at 2025 TWICE VIP Awards

LG Electronics wins the Super VIP Award at the 2025 TWICE VIP Awards, showcasing excellence in various AV and IT products.

Tag: Korea-Japan relations

No posts to display

Top News

- Our Sponsors Ad -

Follow us